Moderna President Stephen Hoge sells about 80,600 shares under a trading plan
Moderna President Stephen Hoge sold 80,575 shares on September 14 and 15, 2026, at weighted average prices of about $144 and $146, for roughly $11.7 million in total. He exercised options with a $12.21 strike price before each sale. The filing says the sales followed a Rule 10b5-1 trading plan adopted on June 15, 2026, which is a pre-arranged plan, not a discretionary sale.
- 80,575 shares sold on September 14 and 15, 2026
- Weighted average sale prices of $144.13 and $146.07
- Total proceeds of roughly $11.7 million
- Sales made under a 10b5-1 plan adopted June 15, 2026
MRNA around the story · hourly24 h reaction ▼ 1.78%
Source
SEC Form 4Sep 14, 2026